Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Chodosh, M.D.

Co-Author

This page shows the publications co-authored by James Chodosh and Hajirah Saeed.
Connection Strength

7.360
  1. Highlights from the 2nd Biennial Stevens Johnson syndrome symposium 2019: SJS/TEN from Science to Translation. Ocul Surf. 2020 07; 18(3):483-486.
    View in: PubMed
    Score: 0.869
  2. The Boston keratoprosthesis. Curr Opin Ophthalmol. 2017 Jul; 28(4):390-396.
    View in: PubMed
    Score: 0.735
  3. Ocular manifestations of Stevens-Johnson syndrome and their management. Curr Opin Ophthalmol. 2016 Nov; 27(6):522-529.
    View in: PubMed
    Score: 0.702
  4. Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Semin Ophthalmol. 2016; 31(1-2):85-90.
    View in: PubMed
    Score: 0.663
  5. Complications of Stevens-Johnson syndrome beyond the eye and skin. Burns. 2016 Feb; 42(1):20-27.
    View in: PubMed
    Score: 0.630
  6. Acute and Chronic Management of Ocular Disease in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis in the USA. Front Med (Lausanne). 2021; 8:662897.
    View in: PubMed
    Score: 0.243
  7. Diphtheroids as Corneal Pathogens in Chronic Ocular Surface Disease in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Cornea. 2021 06 01; 40(6):774-779.
    View in: PubMed
    Score: 0.241
  8. Ochrobactrum anthropi Keratitis in a Boston Type 1 Keratoprosthesis Recipient. Cornea. 2021 May 01; 40(5):662-663.
    View in: PubMed
    Score: 0.240
  9. Chronic ocular complications in lamotrigine vs. trimethoprim-sulfamethoxazole induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Ocul Surf. 2021 07; 21:16-18.
    View in: PubMed
    Score: 0.240
  10. The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease. Ocul Surf. 2021 01; 19:128-132.
    View in: PubMed
    Score: 0.225
  11. Multidisciplinary care in Stevens-Johnson syndrome. Ther Adv Chronic Dis. 2020; 11:2040622319894469.
    View in: PubMed
    Score: 0.224
  12. Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis. Ocul Surf. 2020 07; 18(3):517-522.
    View in: PubMed
    Score: 0.222
  13. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Am J Ophthalmol. 2019 12; 208:331-341.
    View in: PubMed
    Score: 0.212
  14. Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome/toxic epidermal necrolysis. Ocul Surf. 2019 07; 17(3):560-564.
    View in: PubMed
    Score: 0.207
  15. Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye. Cornea. 2018 Nov; 37(11):1408-1413.
    View in: PubMed
    Score: 0.202
  16. Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review. Ocul Surf. 2018 07; 16(3):272-281.
    View in: PubMed
    Score: 0.193
  17. Keratolimbal allograft for limbal stem cell deficiency after severe corneal chemical injury: a systematic review. Br J Ophthalmol. 2018 08; 102(8):1114-1121.
    View in: PubMed
    Score: 0.189
  18. Advances in Imaging of Ocular Surface Tumors. Int Ophthalmol Clin. 2017; 57(4):21-29.
    View in: PubMed
    Score: 0.178
  19. Stevens-Johnson Syndrome and Corneal Ectasia: Management and a Case for Association. Am J Ophthalmol. 2016 09; 169:276-281.
    View in: PubMed
    Score: 0.172
  20. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. Ocul Surf. 2016 04; 14(2):168-88.
    View in: PubMed
    Score: 0.167
  21. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey. Burns. 2016 Jun; 42(4):830-5.
    View in: PubMed
    Score: 0.166
  22. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis--A Comprehensive Review and Guide to Therapy. I. Systemic Disease. Ocul Surf. 2016 Jan; 14(1):2-19.
    View in: PubMed
    Score: 0.164
  23. Ocular manifestations of anti-neoplastic immune checkpoint inhibitor-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in cancer patients. Ocul Surf. 2021 Oct; 22:47-50.
    View in: PubMed
    Score: 0.061
  24. Oral Miltefosine as Salvage Therapy for Refractory Acanthamoeba Keratitis. Am J Ophthalmol. 2021 03; 223:75-82.
    View in: PubMed
    Score: 0.058
  25. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. J Am Acad Dermatol. 2020 Jun; 82(6):1553-1567.
    View in: PubMed
    Score: 0.055
  26. SJS/TEN 2019: From science to translation. J Dermatol Sci. 2020 Apr; 98(1):2-12.
    View in: PubMed
    Score: 0.055
  27. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. J Allergy Clin Immunol Pract. 2018 Jan - Feb; 6(1):38-69.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.